PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide derived from the melanocortin peptide family.
It functions as a melanocortin receptor agonist, with particular research interest in its interactions with MC3R and MC4R receptor subtypes.
Scientific investigations examine its receptor-binding characteristics, intracellular signalling pathways and molecular mechanisms associated with melanocortin receptor activation.
Its cyclic peptide structure contributes to its distinct pharmacological and receptor-binding profile.





